CIK: 0001766721 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 13, 2025
Total Value ($000): $288,452 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma Inc. (BBIO) | 6,068,125 | $209,775 | 72.7% | $40.43 | -16.6% | COM | 10806X102 |
| — | Verona Pharma plc (VRNA) | 615,352 | $39,069 | 13.5% | $7.38 | — | SPONSORED ADS | 925050106 |
| SNDX | Syndax Pharmaceuticals, Inc. (SNDX) | 1,025,000 | $12,587 | 4.4% | $10.24 | +37.7% | COM | 87164F105 |
| BCAX | Bicara Therapeutics Inc. (BCAX) | 568,919 | $7,413 | 2.6% | $25.50 | -47.9% | COM | 055477103 |
| GLUE | Monte Rosa Therapeutics Inc (GLUE) | 1,472,331 | $6,832 | 2.4% | $20.37 | -69.9% | COM | 61225M102 |
| NUVB | Nuvation Bio Inc. (NUVB) | 2,541,009 | $4,472 | 1.6% | $11.18 | -79.6% | COM CL A | 67080N101 |
| CMPS | Compass Pathways Plc (CMPS) | 1,198,418 | $3,427 | 1.2% | $6.51 | — | SPONSORED ADS | 20451W101 |
| BMEA | Biomea Fusion Inc (BMEA) | 798,757 | $1,701 | 0.6% | $17.65 | -80.7% | COM | 09077A106 |
| CALC | CalciMedica, Inc. (CALC) | 521,114 | $995 | 0.3% | $4.55 | -45.2% | COM NEW | 38942Q202 |
| — | Elevation Oncology Inc (ELEV) | 2,834,910 | $735 | 0.3% | $13.57 | — | COM | 28623U101 |
| ACRS | Aclaris Therapeutics Inc (ACRS) | 434,455 | $665 | 0.2% | $10.31 | -79.3% | COM | 00461U105 |
| MRKR | Marker Therapeutics, Inc. (MRKR) | 325,370 | $400 | 0.1% | $1.80 | +1.8% | COM NEW | 57055L206 |
| OKUR | OnKure Therapeutics, Inc. (OKUR) | 88,607 | $381 | 0.1% | $15.14 | -62.9% | COM CL A | 68277Q105 |